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Abstract
Laboratory testing and medication prescription are
two of the most important routines in daily clini-
cal practice. Developing an artificial intelligence
system that can automatically make lab test im-
putations and medication recommendations can
save cost on potentially redundant lab tests and
inform physicians in more effective prescription.
We present an intelligent model that can automat-
ically recommend the patients’ medications based
on their incomplete lab tests, and can even accu-
rately estimate the lab values that have not been
taken. We model the complex relations between
multiple types of medical entities with their inher-
ent features in a heterogeneous graph. Then we
learn a distributed representation for each entity in
the graph based on graph convolutional networks
to make the representations integrate information
from multiple types of entities. Since the entity rep-
resentations incorporate multiple types of medical
information, they can be used for multiple medical
tasks. In our experiments, we construct a graph to
associate patients, encounters, lab tests and medi-
cations, and conduct the two tasks: medication rec-
ommendation and lab test imputation. The experi-
mental results demonstrate that our model can out-
perform the state-of-the-art models in both tasks.
1 Introduction
One of the key goals of precision medicine is the ability
to suggest personalized therapies to patients based on their
molecular and pathophysiologic profiles [Winslow et al.,
2012]. Much work has been devoted to pharmacogenomics
that investigates the link between patient molecular profiles
and drug response [Karczewski et al., 2012]. However, the
status quo is that patient genomics data is often limited while
clinical phenotypic data is ubiquitously available. Thus there
is great potential in linking patient pathophysiologic pro-
files to medication recommendation, a direction we termed
as “pharmacophenomics” that is understudied yet will soon
become imperative. This approach is particularly interesting
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for cancer treatment given the heterogeneous nature of the
disease. In treating cancer patients, physicians typically pre-
scribe medications based on their knowledge and experience.
However, due to knowledge gaps or unintended biases, often
times these clinical decisions can be sub-optimal.
On the other hand, the data quality issue often represents
one of the major impediments of utilizing Electronic Health
Record (EHR) data [Kohane, 2015]. Unlike experimental
data that are collected per a research protocol, the primary
role of clinical data is to help clinicians care for patients, so
the procedures for its collection are often neither systematic
nor on a regular schedule but rather guided by patient condi-
tion and clinical or administrative requirements. Thus, many
aspects of patients’ clinical states may be unmeasured, un-
recorded and unknown in most patients at most time points.
While this “missing data” may be fully clinically appropri-
ate, machine learning algorithms cannot directly accommo-
date missing data. Accordingly, missing clinical phenotypic
data (e.g., laboratory test data) can hinder EHR knowledge
discovery and medication recommendation efforts.
In this paper, we model the complex relations between
multiple types of medical entities with their inherent fea-
tures in a heterogeneous graph, named Medical Graph (Med-
Graph), and propose a medical Graph Convolutional Net-
works (MedGCN) to learn the graph representations for better
medication recommendation and lab test imputation. Figure
1 shows a MedGraph consisting of four types of nodes (i.e.,
encounters, patients, labs and medications), each of which
could have their inherent features, e.g., demographic features
for patients and the chemical composition for medications.
Graph edges encode the relations between the medical en-
tities, for example, a patient may have several encounters,
an encounter may include some lab tests with certain values
and some medication prescriptions. Figure 1 shows scenar-
ios (e.g., encounters 3 and 4) where we may need to impute
missing lab test results and may need to recommend partial
of full list of medications.
To achieve the two tasks in one model, we propose
MedGCN based on the idea of Graph Convolutional Net-
works (GCN). Our main contributions are as follows. (1)
MedGCN extends the GCN model to heterogeneous graphs
and missing feature values in medical settings. (2) We in-
troduce cross regularization, an effective regularization tech-
nique to reduce overfittings using one task to regularize the
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Figure 1: An example of MedGraph. The solid lines represent there
are observed relations between the two objects; the dash lines repre-
sent the relation between the two objects are unknown.
other task. (3) MedGCN is an general inductive model
that could use the learned node representations and network
weights to efficiently generate representation for new data.
(4) Our model can significantly outperform the state-of-the-
art methods for both medication recommendation and lab test
imputation tasks on real EHR data.
2 Related Work
2.1 Medication Recommendation
Following the categorization from [Shang et al., 2019], there
are mainly two types of deep learning methods designed
for medication recommendation: instance-based methods and
Longitudinal methods. instance based methods perform rec-
ommendations ignoring the longitudinal patient history, e.g.
LEAP [Zhang et al., 2017] formulated treatment recommen-
dation as a reinforcement learning problem to predict com-
bination of medications given patient’s diagnoses. Longi-
tudinal methods leverage the temporal dependencies within
longitudinal patient history to predict future medication, e.g.,
DMNC [Le et al., 2018] considers the interactions between
two sequences of drug prescription and disease progression
in the model. GAMENet [Shang et al., 2019] models lon-
gitudinal patient records in order to provide safe medication
recommendation. However, these work focused on one task
while not considering how other tasks affect this task. In
this work, we make the recommendation based on a hetero-
geneous MedGraph that incorporates the complex relations
between multiple types of medical entities.
2.2 Lab Test Imputation
Clinical data often contain missing values for test results.
Imputation uses available data and relationships contained
within it to predict point or interval estimates for missing val-
ues. Numerous imputation algorithms are available [Wal-
jee et al., 2013; Buuren and Groothuis-Oudshoorn, 2010;
Luo et al., 2016; Stekhoven and Bu¨hlmann, 2011], many of
these are designed for cross-sectional imputation (measure-
ments at the same time point). Recent imputation studies
have attempted to model the time dimension [He et al., 2011;
Luo et al., 2017; Kliethermes and Oleson, 2014], but they
generally consider all time points to occur within the same
patient encounters where the temporal correlation between
these time points are strong enough to contribute to impu-
tation accuracy. In our work, the lab test imputation is based
on a MedGraph that incorporates multiple types of medical
entities and their relations.
2.3 Graph Convolutional Networks
Recently, graph convolutional networks (GCN) attracted
wide attention for inducing informative representations of
nodes and edges, and could be effective for tasks that could
have rich relational information between different entities
[Kipf and Welling, 2017; Hamilton et al., 2017a; Chen et al.,
2018; Li et al., 2018b; Yao et al., 2018]. GCN learns node
representations based on the node features and their connec-
tions with the following propagation rule for an undirected
graph [Kipf and Welling, 2017]:
H(k+1) = φ(D˜−
1
2 A˜D˜−
1
2H(k)W (k)) (1)
where A˜ = A + I is the adjacency matrix with added self-
connection, D˜ is a diagonal matrix with D˜ii =
∑
j A˜ij , H
(k)
andW (k) are the node representation matrix and the trainable
parameter matrix for the kth layer, H(0) can be regarded as
the original feature matrix, φ(·) is the activation function.
However, there are two issues that must be effectively tack-
led before extending the original GCN to MedGraph: (1) the
original GCN was designed for homogeneous graphs where
all the nodes are of the same type and have the same features,
i.e., the original feature matrix H(0) should be constructed
with the same features for all the nodes. (2) the original
GCN could not handle missing values in the node features,
i.e., there should not be missing values in feature matrix A.
In medical scenes, a MedGraph could have multiple types
of nodes with different features, and there are many miss-
ing values in the feature matrix. In this paper, we propose
a Medical Graph Convolutional Network model (MedGCN)
that could tackle the above issues for MedGraph, and could
learn informative distributed representations for each node of
MedGraph, base on which, we can not only make medica-
tion recommendation, but also can estimate the missed lab
test values that have not been taken for previous or current
encounters.
3 Methods
3.1 Problem Formulation
Though many types of medical information can be modeled
into a MedGraph, in this paper, to simplify the problem, we
only consider four types of medical entities (i.e., encounters,
patients, labs and medications) and their relations. The meth-
ods can be easily generalized to more entities and relations.
Medication recommendation as multi-label classification
Since an encounter may include multiple medications, we
model medication recommendation as a multi-label classifi-
cation problem. For each medication, the model should out-
put the recommendation probability. If an informative repre-
sentation can be learned for each encounter, this problem can
be tackled by many traditional machine learning algorithms
like logistic regression. Thus the problem is how to effec-
tively integrate the lab information and patient information in
encounter representation learning.
Lab test imputation as matrix completion
Missing lab values imputation is another challenge in en-
counter representation learning. Using an encounter-by-lab
matrix, the imputation problem can be formulated as a matrix
completion problem. Common imputation method such as
mean or median imputation will overlook the correlation be-
tween different columns. In the medical setting, the concur-
rent information such as patients’ baselines and medications
are also useful for lab test imputation. We integrate all these
information in the encounter representations to help impute
the missing labs.
We conduct the two medical tasks with one model
MedGCN where each node can get information from its
neighbors in a layer, and eventually the encounter nodes could
learn informative representations that be used for both medi-
cation recommendation and lab test imputation. In addition,
we can train the model with a cross regularization technique
by which the loss of one task can be regarded as a regulariza-
tion item for the other task.
3.2 MedGraph
We define MedGraph as a specialized graph G = (V, E)
where the nodes V consists of medical entities and the edges
E consists the relations between the medical entities. Med-
Graph is a heterogeneous graph where the nodes V consists
of multiple types of medical entities. For each type of medical
entity, there could be a feature matrix to represent this type of
nodes. In this paper, we will construct a heterogeneous Med-
Graph, and apply GCN to learn the node embeddings.
GCN cannot directly handle the missing values in a node
feature, but can accept an empty edge between two nodes.
This leads to difficulty if one wants to use labs as features
for encounters due to many missing values labs. Instead, we
represent the labs as nodes of type ”lab” that connect with
the encounter node, i.e., we construct a bipartite subgraph be-
tween labs and encounters as part of MedGraph.
The nodes of our MedGraph consists of the the four types
of medical entities, i.e., V = {E,P, L,M}, each node could
have inherent features within it. The relations between two
types of nodes correspond to an adjacency matrix. We defined
the relations between two types of nodes as follows, and the
example adjacency matrices corresponding to the MedGraph
in Figure 1 are shown in Figure 2.
• The relations between encounters and patients are de-
fined in matrix AE×P in Figure 2. If an encounter be-
longs to a patient, there is an edge between the two
nodes, the corresponding position of the adjacency ma-
trix AE×P is set to 1, otherwise, 0. We assume one en-
counter must belong to one and only one patient, and a
patient may have several encounters, there is only one
”1” in each row of the matrix AE×P .
• The relations between encounters and labs are defined in
matrix AE×L in Figure 2. If an encounter includes a lab
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Figure 2: adjacency matrices, AE×P : adjacency matrix between
encounters and patients;AE×M : adjacency matrix between encoun-
ters and medications; AE×L: adjacency matrix between encounters
and labs; ME×M : mask matrix between encounters and labs. Ab-
breviations: P - patient; E - encounter; M - medication; L - lab.
test, there is a weighted edge between the two nodes, the
corresponding position of the adjacency matrixAE×L is
set to the normalized test value between 0 and 1, other-
wise, 0. To discriminate the true test value 0 and the
missing value in the training process, we set another
mask matrix where the corresponding values are set to
1 in true test positions. For example, if the L1 test value
of E2 is 0, the (E2, L1) position is 0 in theAE×L matrix,
while is 1 in the mask ME×L matrix (Figure 2).
• The relations between encounters and medications are
defined in matrix AE×M in Figure 2. If an encounter
includes a medication, there is an edge between the two
nodes, the corresponding position of the adjacency ma-
trix AE×M is set to 1.
• There are no relations between nodes within the same
type except the node itself. The adjacency matrices are
all set as identity matrix.
Medgraph can be generalized to more relations, e.g., if
medication similarities are known, we could construct a
NM × NM matrix to represent the relations between medi-
cations. However, such similarity information often requires
external knowledge source that are not always available and
may be subjective, thus we only consider the above 3 types of
relations in this work. Also note that we did not use diagnosis
code for two reasons. Diagnosis code often are recorded for
billing purposes and may not reflect patients’ true pathology.
Moreover, we want to make MedGCN more practically useful
by not asking physicians to do the heavy lifting in diagnostic
reasoning.
3.3 Heterogeneous GCN
The propagation rule of GCN can be interpreted as the Lapla-
cian smoothing [Li et al., 2018a], i.e., the new feature of
a node is computed as the weighted average of itself and
its neighbors’, followed by a linear transformation. Further,
GCN can be generalized to a graph neural network where
each node can get and integrate messages from its neigh-
borhood to update its representation [Morris et al., 2019;
Hamilton et al., 2017b], i.e., a node v’s representation is up-
dated by
H(k+1)(v) = f
W
(k)
1
1
(
H(k)(v), f
W
(k)
2
2 ({H(k)(w)|w ∈ N(v)})
)
(2)
where N(v) is the neighborhood of v, fW22 aggregates over
the set of neighborhood features and fW11 merges the node
and its neighborhood’s representations. Both fW11 and f
W2
2
could be arbitrary differentiable, permutation-invariant func-
tions. When fW11 and f
W2
2 are sum operations, Eq. 2 is sim-
plified as Eq. 3. [Schlichtkrull et al., 2018]
H(k+1)(v) = φ
 ∑
w∈N(v)∪{v}
H(k)(w) ·W (k)
 (3)
Eq. 3 is designed for a homogeneous graph where all the
samples in N˜(v) = N(v) ∪ {v} share the same linear trans-
formation W (k). It can be shown that Eq. 3 is equivalent to
Eq. 1 except for a normalization coefficient. Though Eq. 1
cannot be directly extended to a heterogeneous graph, Eq. 3
can by recasting it as Eq. 4.
H(k+1)(v) = φ
 n∑
i=1
∑
w∈N˜i(v)
H(k)(w) ·W (k)i
 (4)
where N˜i(v) denotes the ith type of nodes in the neighbor-
hood of v (v included). We can write Eq. 4 in matrix form as:
H
(k+1)
i = φ
 n∑
j=0
Aij ·H(k)j ·W (k)j
 (5)
whereH(k)i is the presentation of the ith type nodes in the kth
layer, Aij is the adjacency matrix between nodes type i and
j, W (k)j is the learnable linear transformation matrix for type
i nodes in layer k.
3.4 MedGCN
Applying the propagation rule Eq. 5 to our MedGraph de-
fined in Section 3.2, we design our MedGCN architecture as
shown in Figure 3. In Figure 3, because encounters have con-
nections to patients, labs and medications, an encounter node
update its representation based on information from neigh-
bors of these types and itself. Similarly, a patient node update
its representation based on its encounters and itself, and lab
nodes, medication nodes all update their information based
on their neighbor encounters and themselves. Eventually, in
the last layer, each nodes would learn a distributed represen-
tation. The representations are then input to two different
neural networks followed by a sigmoid layer for medication
recommendation and lab test imputation, respectively.
P = sigmoid(fθM (HE));V = sigmoid(fθL(HE)) (6)
where for each encounter, the output P = {pij |i =
1, · · · , NE ; j = 1, · · · , NM} is the recommendation prob-
ability of medication j for encounter i. V = {vij |i =
1, · · · , NE ; j = 1, · · · , NL} is the estimated value of lab j
for encounter i.
Loss function
For the medication recommendation task, the true label is the
adjacency matrix AE×M . Since AE×M is very sparse, to fa-
vor the learning of positive classes, we give a weight Nn/Np
to the positive classes, where Nn and Np are the number of
‘0’s and ‘1’s inAE×M , respectively. The binary cross entropy
loss for medication recommendation is defined as
LM (P,A) = − 1
NE
NE∑
i
NM∑
j
Nn
Np
aij log pij+(1−aij) log (1− pij)
(7)
where aij and pij are the values at position (i, j) in matrix A
and P respectively.
For the lab test imputation task, the true value is in the
adjacency matrix AE×L. Since all the missing values are set
to ‘0’s in AE×L which are not the training targets, we use the
mask matrix ME×L to screen the true targets. Since the lab
value are continuous, we use the mean square error loss for
lab test imputation as
LL(V,A) = − 1
NE
NE∑
i
NL∑
j
mij(vij − aij)2 (8)
where aij , vij and mij are the values at position (i, j) in ma-
trix A, V and M respectively.
To learn a MedGCN model that can perform the two tasks,
we use the loss Eq. 9, where λ is used to adjust the proportion
of the two losses.
L = LM (P,AE×M ) + λLL(V,AE×L) (9)
Training strategies: cross regularization
Generally, for medication recommendation task, we only
need LM loss, and for lab test imputation, we only need LL
loss. Nevertheless, even for only one task, we propose to use
the sum loss function Eq. 9. It is a cross regularization tech-
nique between two tasks, i.e., using other tasks to regularize
the target task to reduce overfitting. Beneficially, cross reg-
ularization could make the learned representations more in-
formative, because they would carry information from other
tasks. In this work, when considering the medication recom-
mendation task, λLL can serve as a regularization item that
makes the learned encounter representation carry lab infor-
mation; conversely, when considering the lab test imputation
task, LM plays the role of regularization. We will show that
cross regularization can perform better than using only one
loss in the experiments.
Inductive test
The original GCN is considered transductive, there are some
improved versions based on it for inductive test for new
samples [Hamilton et al., 2017a; Chen et al., 2018]. Our
MedGCN can be inductive based on Eq. 4, for a new test
sample v with its connections, since all the node embeddings
of the graph and the weights of each layer are learned, the
embedding of neighbors of v could be retrieved to compute
the embedding of v by Eq. 4 without retraining the model.
4 Experiments
4.1 Data Sources
We test our MedGCN using real EHR data from a tertiary care
hospital. We select the cohort where the patients have been
diagnosed lung cancer (ICD9=162.x or 231.2, they are neces-
sary for defining the patient cohort), excluding the encounters
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Figure 3: Architecture of MedGCN. Shape and color of the nodes indicate different types of concepts. Here we use plate notation where
the numbers in the corners of plates (NP , NL, NE , NM ) indicate repetitions of the same type of nodes in the MedGraph. Edges with
the same color possess shared weights (parameter sharing). P (patient), E (encounter), M (medication), L (lab) are MedGCN input and
H
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p , H
(k)
e , H
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(k)
l are hidden representations of corresponding nodes at layer k.
#E: 1260; #P: 865; #L: 197, #M: 57
Matrix Size Edges Sparsity Values
AE×P 1260× 865 1260 99.88% binary: 0, 1
AE×L 1260× 197 43806 82.35% continuous: 0–1
AE×M 1260× 57 2475 96.55% binary: 0, 1
Table 1: Dataset and graph information. E=encounters; P=patients;
L=labs; M=medications
that have no medication record or have no lab tests. Eventu-
ally, our dataset consists of 1260 encounters for 865 patients,
they have taken 197 labs and 57 medications related to lung
cancer. Each lab values are normalized to 0-1. According
to these information, we construct a MedGraph like Figure
1. The dataset and MedGraph information are summarized in
Table 1.
4.2 Preprocessing
We split the dataset into a train-val set and a test set with pro-
portion 8:2, the train-val set is further split into training set
and val set by 9:1. Specifically, for medication recommenda-
tion task, the encounters are split into training, validation and
test. In the training process, we remove all edges from the test
and validation encounters to any medications in MedGraph.
For lab test imputation task, the edges between encounters
and labs are split into training, validation and test. In the
training process, we remove all validation and testing edges
in MedGraph. For inductive MedGCN, we remove all test-
ing encounters and their connections from MedGraph when
training. For both tasks, in each training epoch we evaluate
the performance on validation set, the training will early stop
if the validation performance does not get better in 50 epochs.
The best model for validation set is saved to apply on the test
set.
4.3 Evaluation
Settings
Since all types of nodes in the MedGraph have connections
to encounters, a simple 1-layer MegGCN is enough to learn
a informative representation for encounters. We set a 1-layer
MedGCN with the output dimension 300 and dropout rate 0.1
in our experiments. We implement MedGCN with PyTorch
1.0.1, and train it using Adam optimizer [Kingma and Ba,
2015] with learning rate 0.001. The max training epochs is
1000. The cross regularization coefficient λ = 1, we also set
other values for λ, but find λ = 1 performance best.
Baselines
For medication recommendation, we consider several base-
line classification algorithms implemented for multi-label
classification. Our method and baselines are list in Table 2 in
the first column. For the baselines that can not handle miss-
ing values, we simply replace missing values with 0. We have
also tried replace missing values with mean values, the results
did not show any differences. All baselines are implemented
with scikit-learn [Pedregosa et al., 2011].
For lab test imputation, we consider several baselines im-
plemented for matrix completion. Our method and baselines
are list in Table 3 in the first column. Since the 3 baselines
can only process discrete data, when testing the baselines, we
discretize the continuous lab value into 5 ratings for each col-
umn in advance.
Metrics
We use label ranking average precision (LRAP) and mean
average precision at 2 (MAP@2) to measure the performance
of medication recommendation, since the average number of
medications for an encounter is 2. Higher LRAP or MAP
means more accuracy recommendation. We use mean square
error (MSE) to measure the performance of lab test imputa-
tion.
4.4 Results
For MedGCN, we execute the training and test precess 5
times, and record the average performance and standard devi-
ation for both medication recommendation and lab test impu-
tation. For the baselines, we also test them 5 times and record
the corresponding results on their own task.
The results for medication recommendation of our model
and the baselines are listed in Table 2. The results in Table
2 show MedGCN can significantly outperform all the base-
lines with respect to both LRAP and MAP@2. Comparing
Methods LRAP MAP@2
MedGCN (ours) .7374±.0030 .7240±.0044
MedGCN-ind (ours) .7156±.0104 .6954±.0119
MedGCN-Med (ours) .7150±.0022 .6885±.0053
MLP .6800±.0384 .6768±.0192
GBDT [Friedman, 2002] .6908±.0021 .6444±.0026
RF [Breiman, 2001] .6765±.0075 .6817±.0077
LR .7215±0 .6944±.0
SVM [Chang and Lin, 2011] .6306±0 .6161±.0
Table 2: Results for medication recommendation. MedGCN-ind:
inductive MedGCN; MedGCN-Med: MedGCN without cross reg-
ularization and only use Eq. 7 as loss function; MLP: Multi-layer
perceptron; GBDT: Gradient Boosting Decision Tree; RF: Random
Forest; LR: Logistic Regression; SVM: Support Vector Machine.
Methods MSE
MedGCN (ours) .0229±.0025
MedGCN-ind (ours) .0264±.0034
MedGCN-Lab (ours) .0254±.0003
MGCNN [Monti et al., 2017] .0369±.0009
GCMC [Berg et al., 2018] .0426±.0025
GCMC+FEAT [Berg et al., 2018] .0359±.0030
Table 3: Results for lab test imputation. MedGCN-Lab: MedGCN
without cross regularization and only use Eq. 8 as loss function;
MGCNN: Multi-Graph Convolutional Neural Networks; GCMC:
Graph Convolutional Matrix Completion; GCMC+FEAT: GCMC
with side information
MedGCN-Med with MedGCN, the only difference between
the two model is the loss function where MedGCN is cross
regularized by the other task, while MedGCN-Med does not,
the performance of MedGCN is much better than MedGCN-
Med, which validates the efficacy of the cross regularization.
The results for lab test imputation are listed in Table 3. The
results in Table 3 show MedGCN can significantly perform
better than all the baselines. Comparing the performance of
MedGCN-Lab and MedGCN, we can also validate the effi-
cacy of the cross regularization. From Table 2 and 3, although
the test encounters and their connections are removed from
MedGraph in the training process, the inductive MedGCN
implemented according to 4 can also have good performances
for both medication recommendation and lab test imputation.
The main reason why MedGCN works well are two fold:
(1) Because the MedGraph incorporates the complex rela-
tions between different medical entities, MedGCN built on
the informative MedGraph has the potential to learn a much
informative representations for each nodes. (2) To make this
potential into reality, the cross regularization technique makes
the learned representation predictive for multiple tasks. Con-
sidering the baselines in Table 2, they all miss the correlations
between the multiple medications, while MedGCN consider
the relations between medications through their shared en-
counters. In MedGCN-Med, since encounters have got in-
formation from medications, just minimizing loss Eq. 7 to
learn representations predictive to medications will overfit the
training data. MedGCN with cross regularization technique
reduces this overfitting, learns more informative representa-
Available labs Methods Recommendations
uph: 6 True dex, gem, ond
uspg: 1.019 MedGCN ond, dex, gem, peg, bev
LR ond, dex, pem, bev, car
MLP ond, dex, hyd, ral, den
GBDT ond, dex, carb, bev, gem
estimated lab MedGCN GCMC FEAT MGCNN
urobi 0.2 0.19 0.25 0.24 1.01
Table 4: The results of one case study with only two labs
available for medication recommendation and lab test imputation.
FEAT=GCMA+FEAT. ond: ondansetron, dex: dexamethasone,
gem: gemcitabine, peg: pegfilgrastim, bev: bevacizumab, pem:
pemetrexed, car: carboplatin, hyd: hydroxyurea, ral: raloxifene,
den: denosumab, urobi: urobilinogen.
tions and performs better, it can also be validated by compar-
ing the results of MedGCN and MedGCN-Lab in Table 3 for
lab test imputation. Because the baselines in Table 3 miss the
medication and patient information for lab test imputation, it
is expected that they can not perform so well as MedGCN.
4.5 Case Study
We choose an encounter that has only a few lab values avail-
able from the test set to see what medication our model will
recommend, and what lab values will be imputed. As shown
in Table 4, an encounter has two available labs on urine anal-
ysis. Of note, albuminuria was shown to associate with a
2.4-fold likelihood of risk of lung cancer [Jørgensen et al.,
2008]. For medication recommendation, the true medications
are prescribed by doctors and the top 5 recommended med-
ications by different methods are listed in the upper part of
Table 4. No priority in the true medications, sequence prior-
ity exists in the model recommendations. We found the top
3 recommendations of MedGCN are exactly the doctor pre-
scribed medications. LR and MLP missed one medication
in the top 5 recommendations; GBDT recommends a lower
priority for gem.
For lab test imputation for the same encounter, the true
value of lab urobi was taken as 0.2, but we removed it in
the training process. The estimation of this value are listed in
the lower part of Table 4. We can see that our MedGCN pre-
dicts closer to the true value than the baselines. In addition,
MedGCN can perform the two tasks simultaneously.
5 Conclusion
In this paper, we proposed MedGCN, an end-to-end graph
embedding model that could learn informative medical entity
representations for multiple medical tasks. We augmented
MedGCN to handle heterogeneous MedGraph by formulat-
ing different medical entities different types of nodes. By
transforming node features to a new type of nodes in the
graph, MedGCN can also handle missing values in the fea-
tures of a medical entity. MedGCN is an general inductive
model that could use the learned node representations and
network weights to efficiently generate representation for new
nodes. In addition, we introduce cross regularization to re-
duce overfittings by making the learned representation more
informative. Experimental results on a real medical dataset
showed that MedGCN outperformed state-of-the-art methods
in both medication recommendation and lab test imputation
tasks. Our future work includes integrating existing knowl-
edge graphs in the construction of MedGraph, and applying
MedGCN to more cancerous and noncancerous diseases.
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